IP Library › Granted Patent US 6,899,875
Granted Patent B1
US 6,899,875 · App. 10/108,171 · Granted May 31, 2005

Methods and compositions relating to CD39-like polypeptides and nucleic acids

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,899,875
App. No.
10/108,171
Granted
May 31, 2005
Kind
B1
Abstract

The present invention provides novel polynucleotides and proteins encoded by such polynucleotides, along with therapeutic, diagnostic and research utilities for these polynucleotides and proteins. In particular, the polypeptides and polynucleotides of the invention comprise amino acid and nucleic acid sequences of novel CD39-like gene and gene products.

Claims (8)

1. An isolated CD39L3 polypeptide comprising the amino acid sequence of SEQ ID NO: 4.

2. An isolated polypeptide having phosphohydrolase activity consisting of the amino acid sequence of SEQ ID NO: 4.

3. A composition comprising:

(a) a polypeptide selected from the group consisting of:

(i) a polypeptide comprising the amino acid sequence of SEQ ID NO: 4, and

(ii) a polypeptide having phosphohydrolase activity consisting of the amino acid sequence of SEQ ID NO: 4; and

(b) a carrier.

4. The polypeptide according to any one of claims 1 - 2 that comprises amino acid residues 55-76, 132-150, 177-199 or 213-234 of SEQ ID NO: 4.

Assignments (2)
CHANGE OF NAME Recorded Mar 8, 2005
From: HYSEQ, INC..
To: NUVELO, INC
Reel/Frame 015746/0613 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2005
From: IMPERIAL CANCER RESEARCH TECHNOLOGY, LTD.
To: HYSEQ. INC.
Reel/Frame 015701/0948 →